BioPharmSignal logoBioPharmSignal

Biotech News

iSpecimen Reports Third Quarter 2022 Financial and Operating Results

iSpecimen (ISPC)iSpecimen2026-06-25 13:46 ESTEarnings

- Reported Revenue of $2.6 Million, Comprised Of A Record 88% Non-COVID Revenue -

LEXINGTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=sBXaxweR5o98LF9y3CdOPAUl2cIrgnsQNACVpjomM-0PtlZcVFrMKh46PvCwh27g7Vfo-9uvOCNOPBOmVeN6Ng==" rel="nofollow"...

Open original release

Related news

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Report Third Quarter 2022 Results on November 8, 2022

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Appoints Joseph J. Basile to Board of Directors

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Names Tracy Curley as Chief Executive Officer

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on January 25, 2023

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Appoints Eric Langlois as Chief Revenue Officer

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Expands Biospecimen Provider Network

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

View all latest news

iSpecimen

iSpecimen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

ISPCiSpecimen2026-06-26 09:29 EST

iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022

ISPCiSpecimen2026-06-26 09:29 EST

iSpecimen to Report Third Quarter 2022 Results on November 8, 2022

ISPCiSpecimen2026-06-26 09:29 EST

iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network

ISPCiSpecimen2026-06-26 09:29 EST

iSpecimen Reports Third Quarter 2022 Financial and Operating Results

ISPCiSpecimen2026-06-26 09:29 EST

iSpecimen Appoints Joseph J. Basile to Board of Directors

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States